Filing Details

Accession Number:
0001181431-10-021707
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-15 13:00:00
Reporting Period:
2010-04-14
Filing Date:
2010-04-15
Accepted Time:
2010-04-15 16:00:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1296391 Tengion Inc TNGN Biological Products, (No Disgnostic Substances) (2836) 200214813
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378585 David Scheer C/O Tengion, Inc.
2900 Potshop Lane, Suite 100
East Norriton PA 19403
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-14 20,000 $5.00 175,495 No 4 P Indirect See Footnote
Common Stock Acquisiton 2010-04-14 12,894 $0.00 188,389 No 4 C Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 C Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2010-04-14 132,035 $0.00 9,105 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2010-04-14 54,945 $0.00 3,789 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Consists of shares held by Scheer Investment Holdings V, LLC. Mr. Scheer is the managing member of Scheer Investment Holdings V, LLC and may be deemed to have sole or shared voting and investment power with respect to such shares. Mr. Scheer disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
  2. These securities are Preferred Stock of the Issuer and do not have an expiration date. These securities automatically converted into common stock of the Issuer on a 14.5-for-one basis upon the closing of the Issuer's initial public offering of common stock.